transdermal ozone associated with measurable viral load reduction in HCV study
Ozone therapy resulted in 20% of HCV patients achieving PCR-negative status after 2 months and 37.67% after 6 months of treatment.
What this means for you
When the body's immune and oxidative environment shifts, it can affect how viruses replicate and persist. This finding — where a notable share of participants showed undetectable viral markers over time — points to ozone's potential role in supporting the body's own defenses. It's an early but meaningful signal worth understanding.
The published research
OZONE THERAPY IN PATIENTS
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.